Oxford Asset Management’s OptiNose OPTN Stock Holding History

Oxford Asset Management’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,163	Closed	-$161K	–	957
2019 Q4	$161K	Buy	+1,163	New	+$151K	﹤0.01%	1578
2018 Q2	–	Sell	-4,988	Closed	-$1.5M	–	1858
2018 Q1	$1.5M	Sell	4,988 -3,032	-38%	-$840K	0.03%	731
2017 Q4	$2.3M	Buy	+8,020	New	+$2.26M	0.05%	501

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Oxford Asset Management's OPTN Position: Q1 2020 in Review

Oxford Asset Management sold out of OptiNose (OPTN) in Q1 2020, closing a stake of 1,163 shares — an estimated $161K sold.

Oxford Asset Management first reported a position in OPTN in Q4 2017 and held it in 3 quarters. The position peaked at $2.3M in Q4 2017. 81 funds tracked by Wall St. Rank hold OPTN as of Q1 2020.

Oxford Asset Management reported no remaining OptiNose position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 1,163 OptiNose shares in Q1 2020, an estimated $161K.
Oxford Asset Management first reported a position in OptiNose in Q4 2017 and held it in 3 quarters.
Oxford Asset Management's OptiNose position peaked at $2.3M in Q4 2017.
81 funds tracked by Wall St. Rank held OptiNose as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.